News/ News/ R&D Roche bulks up in inflammation with €380m Inflazome acquisition Phil Taylor inflammation, Inflazome, M&A, NLRP3, Roche 0 Comment Roche has made a second acquisition in the area of NLRP3 inhibitors for inflammatory diseases, buying Irish biotech Share X Roche bulks up in inflammation with €380m Inflazome acquisition https://pharmaphorum.com/news/roche-bulks-up-in-inflammation-with-e380m-inflazome-acquisition/
News/ News/ R&D Fox Foundation backs Inflazome Parkinson’s project Phil Taylor Inflazome, Michael J. Fox Foundation, Parkinson's 0 Comment Irish start-up Inflazome has won $1 million in funding from the Michael J. Fox Foundation (MJFF) to help Share X Fox Foundation backs Inflazome Parkinson’s project https://pharmaphorum.com/news/fox-foundation-backs-inflazome-parkinsons-project/
